ACTRN12607000155493已完成4 期
Is Dornase alfa (Pulmozyme ) effective if administered at night, in relation to airways clearance techniques? A multi centre, crossover, randomised controlled trial for people with cystic fibrosis.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 5 Years 至 o limit（—）
- 性别
- All
入选标准
- •With CF attending outpatient clinics; using rhDNase (Pulmozyme); able to perform spirometry; with stable lung disease as assessed by physician at the time of the study; not currently participating in another clinical trial. Stable lung disease was defined as no deterioration in symptoms and no change in chest management for one month (Henry et al, 1998). Patients were excluded if they were currently enrolled in another study or had significant comorbidities (eg unstable diabetes).
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19Patients on mechanical ventilation, inpatient resuscitation for ARDS, secondary to COVID-19 infectionEUCTR2020-001492-33-FRHôpital Fondation Adolphe de Rothschild100
已完成
不适用
Dornase Alpha Versus Hypertonic Saline for Lung Atelectasis in Non-Cystic Fibrosis PatientsAtelectasisNCT00671723University of Oklahoma33
Unknown
2 期
Dornase Alpha for the Treatment of COVID-19COVID-19NCT04432987Acibadem University60
进行中（未招募）
不适用
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock - PROWESS-SHOCKAdults patients with Septic Shock persistently dependent to high dosage of vasopressorsMedDRA version: 9.1Level: LLTClassification code 10040070Term: Septic shockEUCTR2007-005441-38-ITELI LILLY1,500
进行中（未招募）
不适用
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock - PROWESS-SHOCKMedDRA version: 9.1Level: LLTClassification code 10040070Term: Septic shockSeptic shockEUCTR2007-005441-38-NLEli Lilly and Company1,500